UT Health San Antonio Multispecialty and Research Hospital is the first hospital in Texas to approve a non-narcotic ...

Xifyrm is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

On the eve of the International Day Against Drug Abuse and Illicit Trafficking, China released the "China Drug Situation in ...

Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the debut of a powerful new ...

Salicylic acid may disrupt gut microbiota and key metabolites according to a new genetic analysis. Learn more.

2025年1月30日，美国食品药品监督管理局（FDA）批准Vertex Pharmaceuticals的Journavx（Suzetrigine）上市，用于治疗成人中度至重度急性疼痛 ...

Chronic low back pain (CLBP) is a widespread and long-lasting condition defined by lower back pain that lasts for at least 12 weeks. The l ...